Paclitaxel is widely used in the combination chemotherapy for many cancers including esophageal squamous cell carcinoma (ESCC). However, the paclitaxel resistance occurs frequently in treating ESCC and the mechanism is not fully understood yet. The heterogeneity of gene expression within the drug-resistant cancer cells may be one of the major factors contributing to its resistance. In the present study, we successfully induced paclitaxel resistance in ESCC cell line KYSE-30 through low dose and long-term treatment of paclitaxel.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2DY27RH
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Wordle is a toy for generating “word clouds” from text that you provide. The clouds give greater prominence to words that appear more freque...
-
Your source for quotations from famous people and literature. Search or browse over 27,000 quotations from thousands of authors. Includes th...
-
The population of American Indians and Alaska Natives (AIAN) in the USA, which comprise about 5 million individuals, have worse health outco...
-
SMARTCOCKPIT; Our #1 goal, since 2000, is to offer the most extensive online aviation resource to worldwide professional pilots. We desire t...
-
Abstract Purpose C-reactive protein and procalcitonin are reliable early predictors of infection after colorectal surgery. However, the ...
-
Famous Quotes: Hand Picked Funny, Inspirational and Love Quotes. Looking for the best famous quotes? from #AlexandrosSfakianakis via Alexa...
-
Economics articles & eBooks. Essays on topical issues, latest developments in UK and global economies, and answers to readers questions ...
-
Inspirational Quotations offers nature quotes celebrating the beauty of nature, flowers, rainbows, oceans, streams, and meadows. A free insp...
-
<span class="paragraphSection"><div class="boxTitle">Abstract</div>Despite many advances in the study ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου